Teladoc Health, Inc. TDOC shares are volatile Monday, and the stock remains down by more than 11% over the last five days.
What To Know:
Teladoc Health released its third-quarter financial results last Tuesday and reported a loss of 35 cents per share and quarterly revenue of $660.238 billion.
The company also issued fourth-quarter guidance below estimates, with revenue anticipated to be between $658 million and $683 million, versus the $686.56 million estimate.
Last Wednesday, Oppenheimer analyst Michael Wiederhorn maintained Teladoc Health with an Outperform and lowered the price target from $35 to $26, and RBC Capital analyst Sean Dodge maintained the stock with an Outperform and lowered the price target from $35 to $30.
Teladoc Health shares have grabbed the attention of retail investors and short-sellers alike. TDOC is one of the top trending tickers on Stocktwits, and 18.73% of available TDOC shares are being sold short, according to data from Benzinga Pro.
Related News: What's Going On With Coherus BioSciences Stock?
TDOC Price Action: According to Benzinga Pro, Teladoc Health shares are up 2.3% at $15.93 at the time of publication.
Image: Mohamed Hassan from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.